BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28351584)

  • 1. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
    Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
    Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
    Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
    Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
    Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
    Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
    Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
    J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
    J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer.
    Anderson KS; Wong J; D'Souza G; Riemer AB; Lorch J; Haddad R; Pai SI; Longtine J; McClean M; LaBaer J; Kelsey KT; Posner M
    Br J Cancer; 2011 Jun; 104(12):1896-905. PubMed ID: 21654689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer.
    Broglie MA; Jochum W; Michel A; Waterboer T; Foerbs D; Schoenegg R; Stoeckli SJ; Pawlita M; Holzinger D
    Oral Oncol; 2017 Jul; 70():43-50. PubMed ID: 28622890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
    Kreimer AR; Ferreiro-Iglesias A; Nygard M; Bender N; Schroeder L; Hildesheim A; Robbins HA; Pawlita M; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Smoller SW; Ness-Jensen E; Hveem K; D'Souza G; Visvanathan K; May B; Ursin G; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Brenner N; Hoffman-Bolton J; Kaaks R; Barricarte A; Tjønneland A; Sacerdote C; Trichopoulou A; Vermeulen RCH; Huang WY; Freedman ND; Brennan P; Waterboer T; Johansson M
    Ann Oncol; 2019 Aug; 30(8):1335-1343. PubMed ID: 31185496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.
    Anderson KS; Gerber JE; D'Souza G; Pai SI; Cheng JN; Alam R; Kesiraju S; Chowell D; Gross ND; Haddad R; Gillison ML; Posner M
    Oral Oncol; 2015 Aug; 51(8):751-8. PubMed ID: 26094591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
    Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.
    Zhang Y; Waterboer T; Pawlita M; Sugar E; Minkoff H; Cranston RD; Wiley D; Burk R; Reddy S; Margolick J; Strickler H; Weber K; Gillison M; D'Souza G
    Cancer Epidemiol; 2016 Aug; 43():30-4. PubMed ID: 27344614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
    Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
    EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
    Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
    Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
    Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
    Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer.
    Huang CC; Su YC; Chang CC; Lee WT; Ou CY; Wu YH; Wu SY; Lai YH; Huang JS; Chen KC; Hsueh WT; Tsai ST; Yen CJ; Chang JY; Tsai ML; Lin CL; Weng YL; Yang HC; Chen YS; Hsiao JR; Chang JS
    Cancer Med; 2021 Jun; 10(12):4075-4086. PubMed ID: 33949155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
    Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
    Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.